MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2003-05-22
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
38
Registration Number
NCT00006082
Locations
🇫🇷

CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France

Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2003-05-21
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
47
Registration Number
NCT00005868
Locations
🇳🇱

Leiden University Medical Center, Leiden, Netherlands

🇮🇹

Istituto Nazionale per la Ricerca sul Cancro, Genoa (Genova), Italy

🇳🇱

Groot Ziekengasthuis 's-Hertogenbosch, 's-Hertogenbosch, Netherlands

and more 20 locations

Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma

Phase 2
Terminated
Conditions
Lymphoma
First Posted Date
2003-05-07
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
3
Registration Number
NCT00060385
Locations
🇧🇪

U.Z. Gasthuisberg, Leuven, Belgium

Paclitaxel in Treating Patients With Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2003-04-17
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
25
Registration Number
NCT00002972
Locations
🇮🇹

Azienda Ospedale S. Luigi - Universita Di Torino, Orbassano, (Torino), Italy

🇩🇪

Universitaetsklinik und Strahlenklinik - Essen, Essen, Germany

🇧🇪

Centre Hospitalier Regional de la Citadelle, Liege (Luik), Belgium

and more 2 locations

Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 2
Completed
Conditions
Melanoma (Skin)
First Posted Date
2003-04-11
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
90
Registration Number
NCT00002669
Locations
🇮🇹

Istituto Europeo Di Oncologia, Milano, Italy

🇦🇹

Landeskrankenanstalten - Salzburg, Salzburg, Austria

🇧🇪

U.Z. Gasthuisberg, Leuven, Belgium

and more 21 locations

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
First Posted Date
2003-04-11
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
342
Registration Number
NCT00002777
Locations
🇳🇱

St. Elisabeth Ziekenhuis, Tilburg, Netherlands

🇬🇧

Western General Hospital, Edinburgh, Scotland, United Kingdom

🇦🇺

Liverpool Hospital, Liverpool, New South Wales, Australia

and more 45 locations

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

Phase 3
Conditions
Leukemia
First Posted Date
2003-04-11
Last Posted Date
2013-09-20
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
750
Registration Number
NCT00002701
Locations
🇧🇪

Universitair Ziekenhuis Antwerpen, Edegem, Belgium

🇮🇹

Federico II University Medical School, Naples (Napoli), Italy

🇮🇹

Ospedale S. Gennora USL 42, Naples (Napoli), Italy

and more 68 locations

Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma

Phase 3
Completed
Conditions
Sarcoma
First Posted Date
2003-04-10
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
214
Registration Number
NCT00002539
Locations
🇳🇱

University Medical Center Nijmegen, Nijmegen, Netherlands

🇳🇱

Academisch Ziekenhuis Utrecht, Utrecht, Netherlands

🇧🇪

Institut Jules Bordet, Brussels (Bruxelles), Belgium

and more 13 locations

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

Phase 3
Terminated
Conditions
Lymphoma
Interventions
Drug: methoxypsoralen
Procedure: UV light therapy
First Posted Date
2003-03-07
Last Posted Date
2018-07-09
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
93
Registration Number
NCT00056056
Locations
🇫🇷

CHR Hotel Dieu, Nantes, France

🇪🇸

Hospital Universitari de Bellvitge, Barcelona, Spain

🇦🇹

Allgemeines Krankenhaus - Universitatskliniken, Vienna, Austria

and more 25 locations

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

Phase 3
Completed
Conditions
Kidney Cancer
First Posted Date
2003-02-06
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
96
Registration Number
NCT00053807
Locations
🇳🇱

Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands

🇹🇷

Dokuz Eylul University School of Medicine, Izmir, Turkey

🇳🇱

Daniel Den Hoed Cancer Center at Erasmus University Medical Center, Rotterdam, Netherlands

and more 14 locations
© Copyright 2025. All Rights Reserved by MedPath